EQT FUNDS to acquire CORZA BIOSURGERY BUSINESS

EQT Funds has agreed to acquire the Corza Biosurgery Business in a private equity acquisition. This transaction involves the purchase of the healthcare-focused entity by the investment firm. The deal was announced on 30 August 2026. No financial details regarding the consideration or total enterprise value have been disclosed at this stage. The specific currency for any potential valuation remains unreported, and the nature of the consideration structure is not specified in the available records. This acquisition represents a significant move within the healthcare sector, highlighting continued investor interest in biosurgery and medical technology assets. The target operates within a specialised niche, offering advanced surgical solutions that are likely to attract strategic or financial buyers seeking to expand their portfolio capabilities in this growing field.

The transaction is currently subject to ongoing regulatory review processes. As of the latest update, the deal status remains in review, indicating that final completion has not yet been achieved. Both parties are expected to continue cooperating with relevant authorities to ensure all compliance requirements are met before the transfer of ownership can be finalised. Once regulatory hurdles are cleared, the integration of Corza Biosurgery Business into EQT Funds’ portfolio will proceed. This phase is critical for determining the timeline for closing and subsequent operational changes under new management oversight.